NeuroGeneces, Inc.

CIK 1716111 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NeuroGeneces, Inc..

Recent SEC filings

FiledFormAccession number
May 1, 2026D0001716111-26-000006
Jan 28, 2019D/A0001716111-19-000001
Apr 19, 2018D0001716111-18-000001
Sep 11, 2017D0001716111-17-000001